جستجوی استاد راهنمای دانشگاهی

Maria Tenje is a Professor of Microsystems Engineering at the Department of Materials Science , Uppsala University. Since July 2021, she has served as Director of the Department of Medical Technology. She leads the EMBLA research group , focusing on miniaturized systems for life science applications through advanced micro- and nanofabrication methods integrated into microfluidic platforms. Research Interests : Her work centers on biomedical engineering , microfluidics , organ-on-chip technology , and acoustophoresis . Key areas include droplet-based microfluidics, biomaterial evaluation, and developing cell culture systems with enhanced physiological relevance. Recent publications highlight innovations in 3D acoustic mixing , antibiotic resistance detection , and microfluidic platforms for single-cell respiration . Publications Trends : Her 15 most recent articles (2021-2025) span droplet microfluidics, organ-on-chip systems, and acoustic particle manipulation. These studies explore biomaterial biocompatibility , cellular response modeling , and microscale diagnostic tools , often in collaboration with interdisciplinary teams.

• Biomedical Engineering
• Microsystems Engineering
• Microfluidics
• +۵ مورد دیگر

Martin Andersson is a Full Professor in Applied Chemistry at the Department of Chemistry and Chemical Engineering, Chalmers University of Technology. He also serves as Head of Unit and Deputy Head of Department. His research focuses on biomaterials, nanotechnology, and biomedical applications, with a strong emphasis on antimicrobial materials, surface engineering, and tissue-implant interactions. Key areas include the development of nanostructured coatings for medical implants, photothermal antibacterial agents, and drug-delivery systems using mesoporous materials and lyotropic liquid crystals. His work bridges materials science and biomedicine, addressing challenges in infection control, osseointegration, and controlled drug release. Notable projects involve gold nanorods for photothermal therapy, silica-embedded nanoparticles analyzed via atom probe tomography, and antimicrobial hydrogels. Over 135 publications reflect his contributions to journals like ACS Nano , Nano Letters , and Acta Biomaterialia . Research trends highlight innovation in nanomaterial characterization (e.g., THz-driven atom probe tomography), biomimetic mineralization, and functionalized surfaces for medical applications. Collaborations span academia and industry, addressing clinical needs in dentistry, orthopedics, and wound care. Andersson leads research groups focused on advanced materials for healthcare, emphasizing interdisciplinary approaches to improve implant performance and patient outcomes. His labs integrate cutting-edge microscopy, chemical synthesis, and biomedical testing to advance next-generation biomaterials.

• Biomaterials
• Nanotechnology
• Biomedical Engineering
• +۴ مورد دیگر

Xiao-Feng Sun serves as Professor at Linköping University, holding dual appointments in the Department of Biomedical and Clinical Sciences (BKV) and Department of Surgery, Orthopaedics and Oncology (KOO). His research is centered within the Wallenberg Centre for Molecular Medicine (WCMM), a Knut and Alice Wallenberg Foundation initiative advancing molecular medicine through university-healthcare collaboration. His research program investigates molecular drivers of colorectal cancer progression, with emphasis on: MicroRNA-mediated regulation (miR-122, miR-134) of oncogenes like AEG-1 Developmental pathway hijacking (Wnt/β-catenin, TBX3) in metastasis Therapeutic targeting of KRAS/PIK3CA signaling networks Translational validation from murine models to clinical data analysis Recent publications (2024-2025) reveal a cohesive trajectory toward clinical translation, particularly in microRNA-based therapeutics and metastasis intervention. His work bridges basic molecular mechanisms with diagnostic innovation, as evidenced by contributions to emerging colorectal cancer detection methodologies. Professor Sun actively contributes to LiU's cancer research ecosystem, which has secured substantial Swedish Cancer Foundation funding (SEK 24-34 million 2021-2025) for molecular mechanism studies and survival-improvement initiatives. His laboratory leverages WCMM's infrastructure for high-throughput molecular analysis and preclinical validation.

• Molecular Oncology
• Colorectal Cancer Research
• MicroRNA Regulation
• +۳ مورد دیگر

Professor Johan Franck is a leading academic at Karolinska Institutet (KI), Sweden, holding a dual role as Professor in Psychiatry and Senior Physician. He has been affiliated with the Department of Clinical Neuroscience since 2010 and leads the 'Treatment of Addictive Disorders – Johan Franck's Research Group.' His roles include Clinical Director of the Stockholm Centre for Dependency Disorders and former Director of the Stockholm Centre for Psychiatry Research (2007–2011). Education and credentials include a Docent in Physiology/Psychiatry (1999) from KI, Board Certification in Psychiatry (1998), and Addiction Medicine (2018). He has extensive grant leadership, including projects on opioid misuse prevention, mHealth interventions, and pharmacological treatments for stimulant dependence. Research focuses on novel therapies for alcohol and amphetamine dependence, ADHD comorbidity, and translational studies combining neuroimaging and clinical trials. Key themes include pharmacological agents (e.g., methylphenidate, naltrexone), genetic influences on treatment response, and digital health interventions. Recent articles emphasize genetic predictors of treatment outcomes, comparative efficacy of antidepressants, and risk factors in vulnerable populations like homeless individuals. Over 20 years of grants highlight sustained funding for addiction medicine and clinical trials. Supervised students include Amir Sariaslan (neighborhood influences on criminality) and Anna Persson (PhD candidate). Labs/teams: Leads a multidisciplinary group collaborating on opioid use disorder, alcohol post-transplant, and exhaled air testing. Key partnerships include the European Medicines Agency and ICASA (International Collaboration on ADHD and Substance Use Disorders).

• Addiction Medicine
• Substance Use Disorders
• Psychopharmacology
• +۵ مورد دیگر

Jan Johansson is a Professor at the Department of Medicine, Huddinge, Karolinska Institutet, specializing in protein biochemistry and translational research. His work focuses on developing novel medical treatments using molecular chaperones for neurodegenerative diseases like Alzheimer’s, spider silk-based biomaterials, and synthetic surfactants for respiratory disorders. He earned his Medical Degree (1990) and PhD (1991) from Karolinska Institutet, with research spanning protein aggregation mechanisms, drug development, and biomedical applications. Education: MD from Karolinska Institutet (1990), PhD in Biochemistry (1991). Research Interests: Molecular chaperones, protein aggregation, Alzheimer’s disease, spider silk biomaterials, synthetic surfactants. Grants: Multiple projects funded by the Swedish Research Council, VINNOVA, and others, including studies on BRICHOS chaperone mechanisms and biomimetic silk production. His lab explores chaperones’ potential to cross the blood-brain barrier, combat amyloid toxicity, and deliver therapeutic agents. Notable contributions include designing synthetic surfactants for neonatal respiratory distress syndrome and elucidating spider silk’s structural basis for toughness. Collaborations with industries and academic institutions drive translational research toward clinical applications.

• Biochemistry
• Cell and Molecular Biology
• Neurodegenerative Diseases
• +۳ مورد دیگر

Staffan Rosenborg is an Adjunct Lecturer and Docent at Karolinska Institutet's Department of Laboratory Medicine, specializing in the Division of Clinical Pharmacology. His work focuses on drug interactions, pharmacokinetics, and therapeutic drug monitoring, with particular expertise in renal pharmacology and clinical laboratory medicine. His educational background includes: Docent (2022) from Karolinska Institutet PhD in Laboratory Medicine (2010) from Karolinska Institutet Medical Degree (1996) from Karolinska Institutet Dr. Rosenborg's research spans multiple areas of clinical pharmacology with a strong emphasis on drug metabolism, therapeutic drug monitoring, and pharmacokinetics. His work frequently examines drug interactions, particularly those involving cytochrome P450 enzymes, and investigates appropriate dosing strategies for patients with renal impairment. He has conducted significant research on antibiotic effects on microbiota, methylphenidate pharmacokinetics in various populations, and ketone body metabolism in older adults. His expertise bridges clinical practice with laboratory medicine, focusing on translating pharmacological research into practical clinical applications. Analysis of his recent publications reveals a consistent focus on pharmacokinetic studies, drug safety, and therapeutic drug monitoring. His work often involves innovative sampling techniques including exhaled breath and oral fluid analysis as alternatives to traditional blood sampling. A significant portion of his research addresses challenges in renal pharmacology, including drug dosing adjustments for patients with kidney impairment. His studies frequently employ crossover trial designs and utilize advanced analytical methods such as LC-MS/MS for precise drug quantification. Dr. Rosenborg has been involved in the development and evaluation of clinical decision support systems like Janusmed Renal Function, which aids in appropriate drug dosing for patients with renal impairment. His work demonstrates a strong commitment to improving medication safety and optimizing pharmacotherapy through evidence-based approaches.

• Clinical Pharmacology
• Pharmacokinetics
• Drug Interactions
• +۵ مورد دیگر

Eva Wikström is an Associate Professor at Karolinska Institutet, affiliated with the Department of Laboratory Medicine, Division of Clinical Pharmacology. Her clinical expertise includes pharmacological treatment of asthma and COPD, adverse drug reactions, and drug allergy. Doctoral Thesis: Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle (1998). Teaching: Clinical pharmacology for medical students at KI since 2002, pharmacovigilance courses for residents since 2021, and TBL course restructuring. Her research focuses on improving asthma control in primary care through quality-of-life-guided treatment (AQT study), adherence, and inhalation technique. She also investigates asthma/COPD effects on endogenous steroids, drug-drug interactions via Janusmed, and pharmacoepidemiology of adverse drug effects. Recent publications (2023-2019) explore corticosteroid-induced steroid suppression, postpartum medication safety, pediatric asthma treatment disparities, and contextual factors in primary care quality. Earlier works (2010-2009) address asthma severity classification, guideline adherence, and instrument validation for COPD. Clinical Roles: Head of Drug Information at Clinical Pharmacology, Karolinska University Hospital. Education: MD PhD from Karolinska Institutet (1992), Docent in Clinical Pharmacology (2011).

• Pharmacology
• Toxicology
• Respiratory Medicine
• +۵ مورد دیگر

Judith Bruchfeld is a docent in Infectious Diseases and Chief Physician at Karolinska Institutet’s Department of Medicine, Solna, and Karolinska University Hospital. She leads a clinical research group focused on tuberculosis and long-term effects of COVID-19, and has established a multidisciplinary long-COVID clinic to assess patients with persistent symptoms. Her research interests include: Multidrug-resistant tuberculosis (MDR-TB) treatment optimization Pharmacokinetics and drug exposure in TB Long-term sequelae of SARS-CoV-2 infection (PASC) Postural orthostatic tachycardia syndrome (POTS) Microvascular and cardiac dysfunction post-COVID Global TB control and diagnostics Immune responses in TB and post-viral syndromes Her recent publications highlight a strong focus on long-COVID, particularly cardiovascular and autonomic complications, using biomarkers, imaging, and interventional therapies. She also continues to publish extensively on TB, especially drug resistance, dosing, and treatment outcomes in global cohorts. Her work combines clinical research, epidemiology, and translational science. She has contributed to WHO guidelines on latent TB management and is involved in international collaborations on TB and long-COVID. She supervises researchers and leads studies on diagnostic pathways, stigma, and quality of life in TB and post-COVID patients. Her research is supported by grants, including a SEK 19 million award for long-COVID research. She is active in public outreach, media engagement, and advocacy for gender equality in medicine.

• Infectious Diseases
• Tuberculosis
• Multidrug-Resistant Tuberculosis
• +۱۱ مورد دیگر

Ocean Cheung is an Associate Professor and Senior Lecturer at the Department of Materials Science and Engineering, Uppsala University, Sweden. He is affiliated with the Division of Nanotechnology and Functional Materials at the Ångström Laboratory, where he leads the 'Cheungsters' research group focused on functional porous materials. Associate Professor in Engineering Physics (Nanotechnology and Functional Materials), Uppsala University, 2020 PhD in Materials Chemistry, Stockholm University, 2014 MChem in Chemistry, University of Warwick, UK, 2009 His research spans the synthesis and application of inorganic porous materials, particularly targeting environmental and biomedical challenges. Key interests include sol-gel synthesis , drug delivery systems , water treatment , and carbon dioxide capture . His group explores both micro and mesoporous frameworks with functional properties. The publication record shows a strong trend toward multifunctional materials, integrating environmental remediation and biomedical engineering , with a focus on sustainability and practical applications. Research themes include CO₂ sorption, catalytic degradation, and responsive drug carriers using inorganic carbonates. Ocean Cheung has been recognized with prestigious awards: Swedish King Gustaf's 50th Birthday Award for Sciences, Engineering and Environment (2018) Oscar Prize for young scientists (2020) He has mentored students and researchers within his group and secured research funding for projects in nanotechnology and functional materials. His work involves collaborations across Europe, including past affiliations with Heriot-Watt University and Stockholm University. He actively promotes scientific discourse through the MOFCast podcast and maintains a strong digital presence. The Cheungsters group operates at the intersection of chemistry, materials science, and engineering, contributing to sustainable solutions for global challenges in health and environment.

• Porous Materials
• Inorganic Chemistry
• Nanotechnology
• +۹ مورد دیگر

Ksenia Onufrey is a Senior Lecturer at Chalmers University of Technology, affiliated with the Department of Technology Management and Economics and the Division of Innovation and R&D Management. Her work bridges theoretical and applied research in industrial transformation and sustainable systems. Academic Rank: Senior Lecturer Department: Division of Innovation and R&D Management University: Chalmers University of Technology Research Interests focus on: Innovation Management in mature industries Customer involvement in energy service design Strategic alignment of business and technological transitions Sustainable industrial transformation Multi-system linkage dynamics Recent Publications (2019-2026) span topics in: Electric vehicle agenda-setting Activated carbon for CO2 capture Railway brake system thermal analysis DNA-intercalating ruthenium complexes Food material microstructure engineering Biomass-derived adsorbent technology

• Innovation Management
• Sustainable Energy Systems
• Business Strategy
• +۴ مورد دیگر

Thomas Ederth is an Associate Professor and Head of the Department of Biophysics and Biotechnology at Linköping University's Department of Physics, Chemistry and Biology (IFM). With a PhD in Molecular Physics from KTH Royal Institute of Technology (1999) and postdoctoral experience at the University of Oxford, Ederth specializes in surface chemistry and biointerface interactions. Research Interests Surface chemistry of biological material interactions Marine biofouling and antifouling polymers Lipid bilayer and membrane interactions Neutron reflectometry and vibrational spectroscopy Electroactive polymer analysis Method development for surface-sensitive techniques Publication Trends Ederth's recent work spans marine biotechnology (antifouling coatings, bioadhesion), biomedical applications (lysosomotropic agents, toxicity studies), and advanced materials characterization (neutron scattering, Raman spectroscopy). Key methods include neutron reflectivity, vibrational spectroscopy, and surface-enhanced Raman analysis. Teaching Roles Course Manager for TFYA35 Molecular Physics Examiner for TFYA47 Surfaces and Boundary Layers

• Surface Chemistry
• Marine Biotechnology
• Biocompatibility
• +۵ مورد دیگر

My Hedhammar is Professor in Biotechnology at KTH Royal Institute of Technology developing innovative methods for tissue engineering using recombinant spider silk. Her laboratory creates three-dimensional tissue models that mimic natural cellular environments. Research focuses on spider silk-derived biomaterials that serve as scaffolds for cell cultivation, enabling the creation of complex tissue structures including vascularized models. Applications include cancer tumor modeling and diabetes treatment through pancreatic islet transplantation. Recent publications (2023-2025) demonstrate advancements in silk functionalization, cryopreservation techniques, and disease-specific models. Work consistently bridges biomaterial science with clinical applications in regenerative medicine and drug development.

• Tissue Engineering
• Biomaterials
• Spider Silk Applications
• +۳ مورد دیگر

Anders Franco-Cereceda is a Professor/Senior Physician at Karolinska Institutet, leading the Thoracic Surgery research group within the Department of Molecular Medicine and Surgery. He specializes in cardiothoracic surgery and translational research, focusing on aortic valve and thoracic aortic diseases. His work spans molecular mechanisms, surgical techniques, and patient outcomes, with significant contributions to understanding aortic aneurysms and valve pathophysiology. Education & Career: MD from Karolinska Institutet (1992) PhD in Pharmacology (1988) Postdoc at Cleveland Clinic (1999–2000) Became a board-certified cardiothoracic surgeon (1997) and Professor (2005) Research Interests: Mechanisms of aortic valve degeneration and aneurysm formation Genetic and molecular drivers of cardiovascular diseases Surgical innovations and patient risk stratification Collaborations on international projects like FAD (EU), MIBAVA (Fondation Leducq), and NORCAAD Key Contributions: PI of ASAP, DAVAACA, and ARTIST studies analyzing 3,000+ surgical patients Over 300 publications, 17,000+ citations, and an H-index of 60 (2024) Recipient of awards including the Evarts A. Graham Memorial Fellowship Leadership: Head of Department of Molecular Medicine and Surgery (2021–2025) Guides a multidisciplinary team including PhD students and postdocs

• Cardiovascular Disease
• Thoracic Surgery
• Cardiology
• +۶ مورد دیگر

Dorota Religa is a Professor and Senior Physician at Karolinska Institutet's Department of Neurobiology, Care Sciences and Society, where she leads the Dementia and Multimorbidity research group. She specializes in dementia, Alzheimer's disease, aging, and frailty, with a focus on registry-based studies using the Swedish Dementia Registry (SveDem) to improve care for patients with cognitive impairment and comorbidities. Her research examines diabetes-dementia interactions, blood biochemistry trajectories, antipsychotic treatments for behavioral symptoms, and multidisciplinary approaches to neurodegenerative disorders. She has supervised over 50 doctoral and master's students, including projects on cardiovascular comorbidities, caregiver mental health, and pharmacoepidemiology. Religa's recent publications focus on COVID-19 impacts in older adults, dementia care disparities, and novel diagnostic technologies. She collaborates internationally on projects like RADAR-AD for remote dementia monitoring. Grants supporting her work include funding from the Swedish Research Council, Stockholm County Council (ALF), Alzheimerfonden, and Horizon 2020. Her laboratory investigates modifiable risk factors in dementia, emphasizing clinical translation and health system improvements.

• Multimorbidity
• Frailty
• Dementia
• +۳ مورد دیگر

Professor Amit Kumar-Mishra is affiliated with Halmstad University's Department of Artificial Intelligence and Sensor Technologies. His research spans interdisciplinary areas including AI-driven solutions for precision agriculture, drug delivery systems, cancer biology, and molecular imaging. He has authored over 30 publications in 2024-2025 alone, focusing on topics like pH-responsive nanocarriers for cancer therapy, circular RNA roles in cytokine signaling, and weed management strategies in mustard crops. Notable research contributions include development of deep neural network architectures for sensor technologies, investigation of salt stress adaptations in eggplant, and exploration of proteases for cancer diagnostics. His work integrates machine learning with agricultural challenges, such as real-time weed detection systems and hydroponics automation. Recent studies also explore novel biomarkers for ovarian cancer detection using circulating DNA analysis. Publications demonstrate a strong focus on translational research with applications in both clinical oncology and agricultural productivity. His research bridges computational methods with biological systems, emphasizing cross-disciplinary innovation in healthcare and food security domains.

• Artificial Intelligence
• Sensor Technologies
• Drug Delivery Systems
• +۴ مورد دیگر